Exogenous TGFβ1 and its mimic HpTGM attenuate the heart's inflammatory response to ischaemic injury and improve long term cardiac outcomes
R. E. Redgrave, E. Singh, S. Tual-Chalot, C. Park, D. Hall, K. Bannaceur, D. Smyth, R. M. Maizels, I. Spyridopoulos, H. M. Arthur
This study shows that exogenous TGFβ1 and its mimic HpTGM reduce inflammation and infarct size after myocardial infarction, improving cardiac outcomes.
bioRxiv · Apr 18, 2023 · PreprintPathology